Understand the compound before you order the vial.

DSIP

Delta Sleep-Inducing Peptide+2

A nonapeptide with older sleep-related human and animal literature, but limited modern clinical evidence and unresolved biology.

Dihexa

Nle1-AngIV-related analog

An angiotensin-IV-related small molecule studied in synaptogenesis and cognition models.

Oxytocin

An endogenous neuropeptide and hormone with established pharmaceutical uses and broad research biology.

Epitalon

Epithalon

A synthetic tetrapeptide associated with limited and largely preclinical aging-related literature.

Adamax

Synthetic Semax+1

A synthetic Semax-related research peptide; exact sequence equivalence to Semax requires batch documentation.

KLOW

KPV + TB-500 + BPC-157 + GHK-Cu blend

A four-peptide research blend containing KPV, TB-500, BPC-157, and GHK-Cu.

GLT-2

Tirzepatide+2

GLT-2 is the catalog display code for Tirzepatide, a dual GIP/GLP-1 receptor agonist with extensive human evidence and approved pharmaceutical products.

Cagrilintide

AM833

An amylin-analog peptide studied in weight-management and metabolic clinical trials.

NAD+

NAD+1

A central redox and metabolic cofactor; not a peptide despite its placement in the compound catalog.

Glutathione

GSH+1

A redox-active tripeptide and cellular antioxidant system component; not a catalog peptide research claim by itself.

AHK-Cu

AHK copper peptide

A copper-peptide research label with a much smaller directly located literature base than GHK-Cu.

GHK-Cu

Copper tripeptide-1+1

A copper-binding tripeptide studied in skin, extracellular-matrix, and wound-response models.

Ipamorelin

A synthetic pentapeptide studied as a selective growth-hormone secretagogue through the GHS receptor pathway.

Tesamorelin

TH9507+1

A GHRH analog with clinical evidence and a specific FDA-approved pharmaceutical indication.

ARA-290

pHBSP+1

A non-erythropoietic erythropoietin-derived peptide studied in neuropathy and tissue-protection research.

VIP

Vasoactive Intestinal Peptide

An endogenous neuropeptide with broad receptor biology and indication-specific research.

Semax

Met-Glu-His-Phe-Pro-Gly-Pro

A synthetic ACTH-fragment analog with region-specific clinical and preclinical literature.

Selank

TP-7

A synthetic peptide studied primarily in limited and region-specific neuropharmacology literature.

5-Amino-1MQ

A small-molecule NNMT research inhibitor label, not a peptide.

PT-141 / Bremelanotide

Bremelanotide+1

A melanocortin-receptor agonist whose approved pharmaceutical identity is bremelanotide.

MOTS-c

Mitochondrial open reading frame of the 12S rRNA-c

A mitochondria-derived peptide studied in metabolic, exercise, and cellular stress research.

CJC-1295 No DAC

CJC-1295 NO DAC

A growth-hormone-releasing hormone analog label with limited directly matched evidence for the no-DAC form.

SS-31 / Elamipretide

MTP-131+2

A mitochondria-targeted peptide studied in preclinical and clinical research.

BPC-157 + TB-500 Wolverine

Wolverine blend

A combination SKU; evidence for its commercial blend is not established by studies of either constituent alone.

TB-500

Thymosin beta-4-related research label+1

A commercial research label whose exact identity must be verified against batch documentation.

BPC-157

Body Protection Compound-157+1

A synthetic pentadecapeptide with a largely preclinical literature base.

GLR-3

Retatrutide+2

GLR-3 is the catalog display code for Retatrutide (LY3437943), an investigational triple agonist of the GIP, GLP-1, and glucagon receptors.

KPV

Lys-Pro-Val+1

A melanocortin-derived tripeptide studied mainly in cell and animal inflammation models.